User menu

Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program.

Bibliographic reference Chabannon, C ; Pamphilon, D ; Vermylen, Christiane ; Gratwohl, A ; Niederwieser, D ; et. al. Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program.. In: Bone Marrow Transplantation, Vol. 47, no. 1, p. 15-17 (2012)
Permanent URL http://hdl.handle.net/2078/123862
  1. Pamphilon Derwood, Apperley Jane F., Samson Diana, Slaper-Cortenbach Ineke, McGrath Eoin, JACIE Accreditation in 2008, 10.1016/s1658-3876(09)50019-2
  2. LeMaistre C. Fred, Loberiza Fausto R., What is quality in a transplant program?, 10.1016/j.bbmt.2004.12.329
  3. Gratwohl Alois, Baldomero Helen, Trends of hematopoietic stem cell transplantation in the third millennium : , 10.1097/moh.0b013e328330990f
  4. Gratwohl A, Baldomero H, Frauendorfer K, Rocha V, Apperley J, Niederwieser D, The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products, 10.1038/sj.bmt.1705956
  5. Gratwohl Alois, Hematopoietic Stem Cell TransplantationA Global Perspective, 10.1001/jama.2010.491
  6. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A, Niederwieser D, Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors, 10.1038/sj.bmt.1705555
  7. Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K, Niederwieser D, The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies, 10.1038/bmt.2009.7
  8. Apperley J, Just Another Cost Increasing Exercise (JACIE)?, 10.1038/sj.bmt.1704651
  9. Tricot G, Cottler-Fox M H, Calandra G, Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization, 10.1038/bmt.2009.130
  10. Afolalu B, Perit Dial Int, 29, 292 (2009)
  11. Klingebiel T., Cornish J., Labopin M., Locatelli F., Darbyshire P., Handgretinger R., Balduzzi A., Owoc-Lempach J., Fagioli F., Or R., Peters C., Aversa F., Polge E., Dini G., Rocha V., , Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group, 10.1182/blood-2009-03-207001
  12. Storb Rainer, Deeg H. Joachim, Whitehead John, Appelbaum Frederick, Beatty Patrick, Bensinger William, Buckner C. Dean, Clift Reginald, Doney Kristine, Farewell Vernon, Hansen John, Hill Roger, Lum Lawrence, Martin Paul, McGuffin Robert, Sanders Jean, Stewart Patricia, Sullivan Keith, Witherspoon Robert, Yee Gary, Thomas E. Donnall, Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia, 10.1056/nejm198603203141201
  13. Allogeneic Peripheral Blood Stem-Cell Compared With Bone Marrow Transplantation in the Management of Hematologic Malignancies: An Individual Patient Data Meta-Analysis of Nine Randomized Trials, 10.1200/jco.2005.09.020
  14. Rocha V., Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia, 10.1182/blood.v97.10.2962
  15. Niederwieser D., Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases, 10.1182/blood-2002-05-1340